Literature DB >> 20080957

Muscarinic receptor stimulation of D-aspartate uptake into human SH-SY5Y neuroblastoma cells is attenuated by hypoosmolarity.

Daniel J Foster1, Anne M Heacock, Stephen K Fisher.   

Abstract

In addition to its function as an excitatory neurotransmitter, glutamate plays a major role as an osmolyte within the central nervous system (CNS). Accordingly, mechanisms that regulate glutamate release and uptake are of physiological importance not only during conditions in which cell volume remains constant but also when cells are subjected to hypoosmotic stress. In the present study, the ability of muscarinic cholinergic receptors (mAChRs) to regulate the uptake of glutamate (monitored as D-aspartate) into human SH-SY5Y neuroblastoma cells under isotonic or hypotonic conditions has been examined. In isotonic media, agonist activation of mAChRs resulted in a significant increase (250-300% of control) in the uptake of D-aspartate and, concurrently, a cellular redistribution of the excitatory amino acid transporter 3 (EAAT3) to the plasma membrane. mAChR-mediated increases in d-aspartate uptake were potently blocked by the EAAT3 inhibitor l-beta-threo-benzyl-aspartate. In hypotonic media, the ability of mAChR activation to facilitate D-aspartate uptake was significantly attenuated (40-50%), and the cellular distribution of EAAT3 was disrupted. Reduction of mAChR-stimulated D-aspartate uptake under hypoosmotic conditions could be fully reversed upon re-exposure of the cells to isotonic media. Under both isotonic and hypotonic conditions, mAChR-mediated increases in D-aspartate uptake depended on cytoskeletal integrity, protein kinase C and phosphatidylinositol 3-kinase activities, and the availability of intracellular Ca2+. In contrast, dependence on extracellular Ca2+ was observed only under isotonic conditions. The results suggest that, although the uptake of D-aspartate into SH-SY5Y cells is enhanced after mAChR activation, this process is markedly attenuated by hypoosmolarity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20080957      PMCID: PMC2846019          DOI: 10.1124/jpet.109.164277

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  34 in total

1.  Agonist-induced endocytosis of muscarinic cholinergic receptors: relationship to stimulated phosphoinositide turnover.

Authors:  S D Sorensen; E L McEwen; D A Linseman; S K Fisher
Journal:  J Neurochem       Date:  1997-04       Impact factor: 5.372

2.  Desensitization of the beta-adrenergic receptor of frog erythrocytes. Recovery and characterization of the down-regulated receptors in sequestered vesicles.

Authors:  J M Stadel; B Strulovici; P Nambi; T N Lavin; M M Briggs; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1983-03-10       Impact factor: 5.157

3.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

4.  Interaction of L-cysteine with a human excitatory amino acid transporter.

Authors:  N Zerangue; M P Kavanaugh
Journal:  J Physiol       Date:  1996-06-01       Impact factor: 5.182

5.  Muscarinic receptor regulation of cytoplasmic Ca2+ concentrations in human SK-N-SH neuroblastoma cells: Ca2+ requirements for phospholipase C activation.

Authors:  S K Fisher; L M Domask; R M Roland
Journal:  Mol Pharmacol       Date:  1989-02       Impact factor: 4.436

6.  Reduction of muscarinic receptor density and of guanine nucleotide-stimulated phosphoinositide hydrolysis in human SH-SY5Y neuroblastoma cells following long-term treatment with 12-O-tetradecanoylphorbol 13-acetate or mezerein.

Authors:  C L Cioffi; S K Fisher
Journal:  J Neurochem       Date:  1990-05       Impact factor: 5.372

7.  Relationship between agonist-induced muscarinic receptor loss and desensitization of stimulated phosphoinositide turnover in two neuroblastomas: methodological considerations.

Authors:  A K Thompson; S K Fisher
Journal:  J Pharmacol Exp Ther       Date:  1990-02       Impact factor: 4.030

8.  Cytoskeleton-related trafficking of the EAAC1 glutamate transporter after activation of the G(q/11)-coupled neurotensin receptor NTS1.

Authors:  Mustapha Najimi; Jean Marie Maloteaux; Emmanuel Hermans
Journal:  FEBS Lett       Date:  2002-07-17       Impact factor: 4.124

9.  Depletion of glutathione from brain cells in hyponatremia.

Authors:  E C Clark; D Thomas; J Baer; R H Sterns
Journal:  Kidney Int       Date:  1996-02       Impact factor: 10.612

10.  Rapid trafficking of the neuronal glutamate transporter, EAAC1: evidence for distinct trafficking pathways differentially regulated by protein kinase C and platelet-derived growth factor.

Authors:  Keith M Fournier; Marco I González; Michael B Robinson
Journal:  J Biol Chem       Date:  2004-06-14       Impact factor: 5.157

View more
  4 in total

Review 1.  Receptor regulation of osmolyte homeostasis in neural cells.

Authors:  Stephen K Fisher; Anne M Heacock; Richard F Keep; Daniel J Foster
Journal:  J Physiol       Date:  2010-05-24       Impact factor: 5.182

Review 2.  The importance of the excitatory amino acid transporter 3 (EAAT3).

Authors:  Walden E Bjørn-Yoshimoto; Suzanne M Underhill
Journal:  Neurochem Int       Date:  2016-05-24       Impact factor: 3.921

Review 3.  Rapid Regulation of Glutamate Transport: Where Do We Go from Here?

Authors:  Alain M Guillem; Elizabeth N Krizman; Michael B Robinson
Journal:  Neurochem Res       Date:  2021-04-24       Impact factor: 3.996

4.  d-Amino Acid Peptide Residualizing Agents for Protein Radioiodination: Effect of Aspartate for Glutamate Substitution.

Authors:  Marek Pruszynski; Choong Mo Kang; Eftychia Koumarianou; Ganesan Vaidyanathan; Michael R Zalutsky
Journal:  Molecules       Date:  2018-05-20       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.